Oleaone Eye Drop 0.1% (Olopatadine Hydrochloride)

Adult eye dose

Instill 1 drop once, twice a day (at intervals of 6-8 hours). Treatment may continue for up to 4 months if necessary.

This medication should not be used by individuals with an allergy to the active ingredient or any of its components. While using this medicine, symptoms such as headaches or taste disturbances may rarely occur, and dizziness may also arise. For eye-related issues, symptoms such as punctate keratitis, keratitis, eye pain, dry eyes, eye swelling, itching, discharge, congestion, keratinization, and discomfort may occur. Additionally, glare or blurred vision, and eyelid redness have been reported rarely. Dryness of the nose or symptoms of rhinitis may occur, and dry mouth is also rarely observed. Contact dermatitis may develop on the skin, and individuals may experience generalized fatigue. In rare cases, usage of this medication may lead to increased sensitivity of the eyes or symptoms such as lethargy, cold symptoms, nausea, pharyngitis, sinusitis, skin erythema, abdominal pain, liver dysfunction, jaundice, elevated blood pressure, decreased white blood cells and lymphocytes, renal dysfunction, and urinary difficulties. This medication contains phosphate, so there is a very rare risk of corneal calcification in patients with severe corneal damage. This is a non-sedating antihistamine, and may temporarily cause blurred vision after use, so one should wait until vision is clear before driving or operating machinery. Patients undergoing long-term steroid treatment should gradually reduce the steroid dosage according to a doctor's instructions when using this medication. It is advisable for individuals with seasonal allergies to start using this medication before symptoms worsen and to continue using it during the symptom period. Care should be taken to avoid long-term use if no effect is observed. Benzalkonium chloride, which is present in this medication, can cause eye irritation and discoloration of soft contact lenses, therefore it should not be used while wearing contact lenses, and lenses should be put on at least 15 minutes after application. Contact lens wear should be avoided if the eyes are red. During pregnancy, safety for the fetus has not been established, therefore it should be used cautiously under a doctor's judgment. During breastfeeding, the medication may be excreted in breast milk and potentially affect the infant, thus usage should be discussed with a doctor. The safety and efficacy for children under 3 years old have not been confirmed. No special dosage adjustments are needed for the elderly. In case of overdose, appropriate monitoring and treatment are necessary. This medication is for direct ophthalmic use only, and other administration methods may be hazardous. Care should be taken to avoid contact between the container opening and the eye or hands, and the cap should be tightly sealed after use to prevent contamination. If using with other eye drops, a minimum interval of 5 minutes should be maintained, and eye ointments should be used last. This medication should be stored in a closed container that protects it from light, in a cool place, out of reach of children. To maintain quality, it should not be transferred to another container.

Serious side effects

• Liver dysfunction
• jaundice
• elevated blood pressure
• urinary difficulties.

Mild side effects

• Headache
• taste disturbances
• dizziness
• punctate keratitis
• keratitis
• eye pain
• dry eyes
• eyelid edema
• eye itching
• eye discharge

This medication is sensitive to light, so it should be stored in a closed container that protects it from light. It is important to maintain a storage temperature between 4°C and 25°C. By doing so, the efficacy and stability of the medication can be preserved for a longer period.

Appearance

A colorless to pale yellow solution in an opaque white plastic container for eye drops.

Package unit

6mL/bottle